Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Committee Composition

Committee Composition

  Audit Nominating and Corporate Governance Compensation
Raymond W. Cohen Member of Audit Committee Member of Nominating and Corporate Governance Committee Committee Chair for Compensation Committee
Stuart M. Krassner,, ScD, PsyD Member of Audit Committee Member of Nominating and Corporate Governance Committee  
Luigi Lenaz, MD   Committee Chair for Nominating and Corporate Governance Committee Member of Compensation Committee
Anthony E. Maida III,, PhD, MA, MBA Committee Chair for Audit Committee Member of Nominating and Corporate Governance Committee Member of Compensation Committee
Dolatrai M. Vyas, PhD   Member of Nominating and Corporate Governance Committee Member of Compensation Committee
Committee Chair = Chair Committee Member = Member

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
4.73
Change:
- 0.01
Day High:
4.81
Day Low:
4.64
Volume:
636,336
4:00 PM ET on Sep 28, 2016
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR